Leaflet CYTOTECT CP BIOTEST 100U / ml solution for infusion


Indicated for: immunosuppression

Route of administration: infusion

Substance: human anti-cytomegalovirus immunoglobulin (immunoglobulin)

ATC: J06BB09 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Human anti-cytomegalovirus immunoglobulin is a plasma-derived product used to prevent or treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as transplant recipients. It provides passive immunity by supplying specific antibodies against CMV.

The medication is administered via intravenous injection under the supervision of a specialist.

Side effects may include fever, chills, headache, or infusion site reactions. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should be closely monitored during administration and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about CYTOTECT CP BIOTEST 100U / ml

  • Substance: human anti-cytomegalovirus immunoglobulin
  • Date of last drug list: 01-05-2026
  • Commercial code: W69368002
  • Concentration: 100U / ml
  • Pharmaceutical form: solution for infusion
  • Quantity: 1
  • Product type: original
  • Price: 4856.61 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BIOTEST PHARMA GMBH - GERMANIA
  • Holder: BIOTEST PHARMA GMBH - GERMANIA
  • Number: 14855/2023/02
  • Shelf life: 3 years